Construction of manganese porphyrin modified hemoglobin complex and its antioxidant activities

Hidenori Murata, Yuji Ito, Tomoyuki Shimpo, Kenichi Oyaizu, Makoto Yuasa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Manganese 5,10,15,20-tetrakis(N-methyl-2-yl) porphyrin (MnT2MePyP) was introduced to hemoglobin to use it as a drug carrier. Reconstituted hemoglobin was reacted with pyridoxal-5-phosphate and borohydride to yield pyridoxalated reconstituted hemoglobin (PLPrHb). The reaction of PLPrHb with activated polyethyleneglycol gave pegylated reconstituted hemoglobin (PEGrHb). PEGrHb was polymerized using glutaraldehyde to yield cross-linked pegylated reconstituted hemoglobin (Cross-link PEGrHb). The number average moleculer weight of Cross-link PEGrHb was estimated to be 1.0 _Xt 105 by GPC. The modification of hemoglobin was checked by using SDS-PAGE. Stopped flow analysis showed a high SOD activity of Cross-link PEGrHb. A pharmacokinetic study of 125I-labelled Cross-link PEGrHb that was infused into mice revealed a long-term blood circulation. The novel Manganese porphyrin modified hemoglobin complex was found to remain long-term in the blood circulation without being removed by excretion. These results showed that this complex can be used as a high performance antioxidant.

Original languageEnglish
Pages (from-to)277-282
Number of pages6
JournalKobunshi Ronbunshu
Volume65
Issue number4
DOIs
Publication statusPublished - 2008 Apr
Externally publishedYes

Fingerprint

porphyrin
Hemoglobin
Porphyrins
hemoglobin
Manganese
Antioxidants
antioxidant
manganese
Hemoglobins
Hemodynamics
blood
Borohydrides
Drug Carriers
Pyridoxal Phosphate
Pharmacokinetics
Glutaral
excretion
Phosphates
drug
phosphate

Keywords

  • Antioxidant
  • Cross-link
  • Hemoglobin
  • Manganese porphyrin

ASJC Scopus subject areas

  • Polymers and Plastics
  • Environmental Science(all)
  • Materials Science (miscellaneous)
  • Chemical Engineering (miscellaneous)
  • Ceramics and Composites

Cite this

Construction of manganese porphyrin modified hemoglobin complex and its antioxidant activities. / Murata, Hidenori; Ito, Yuji; Shimpo, Tomoyuki; Oyaizu, Kenichi; Yuasa, Makoto.

In: Kobunshi Ronbunshu, Vol. 65, No. 4, 04.2008, p. 277-282.

Research output: Contribution to journalArticle

Murata, Hidenori ; Ito, Yuji ; Shimpo, Tomoyuki ; Oyaizu, Kenichi ; Yuasa, Makoto. / Construction of manganese porphyrin modified hemoglobin complex and its antioxidant activities. In: Kobunshi Ronbunshu. 2008 ; Vol. 65, No. 4. pp. 277-282.
@article{41695eecffb7457d81fa53464918b34f,
title = "Construction of manganese porphyrin modified hemoglobin complex and its antioxidant activities",
abstract = "Manganese 5,10,15,20-tetrakis(N-methyl-2-yl) porphyrin (MnT2MePyP) was introduced to hemoglobin to use it as a drug carrier. Reconstituted hemoglobin was reacted with pyridoxal-5-phosphate and borohydride to yield pyridoxalated reconstituted hemoglobin (PLPrHb). The reaction of PLPrHb with activated polyethyleneglycol gave pegylated reconstituted hemoglobin (PEGrHb). PEGrHb was polymerized using glutaraldehyde to yield cross-linked pegylated reconstituted hemoglobin (Cross-link PEGrHb). The number average moleculer weight of Cross-link PEGrHb was estimated to be 1.0 _Xt 105 by GPC. The modification of hemoglobin was checked by using SDS-PAGE. Stopped flow analysis showed a high SOD activity of Cross-link PEGrHb. A pharmacokinetic study of 125I-labelled Cross-link PEGrHb that was infused into mice revealed a long-term blood circulation. The novel Manganese porphyrin modified hemoglobin complex was found to remain long-term in the blood circulation without being removed by excretion. These results showed that this complex can be used as a high performance antioxidant.",
keywords = "Antioxidant, Cross-link, Hemoglobin, Manganese porphyrin",
author = "Hidenori Murata and Yuji Ito and Tomoyuki Shimpo and Kenichi Oyaizu and Makoto Yuasa",
year = "2008",
month = "4",
doi = "10.1295/koron.65.277",
language = "English",
volume = "65",
pages = "277--282",
journal = "Kobunshi Ronbunshu",
issn = "0386-2186",
publisher = "Society of Polymer Science",
number = "4",

}

TY - JOUR

T1 - Construction of manganese porphyrin modified hemoglobin complex and its antioxidant activities

AU - Murata, Hidenori

AU - Ito, Yuji

AU - Shimpo, Tomoyuki

AU - Oyaizu, Kenichi

AU - Yuasa, Makoto

PY - 2008/4

Y1 - 2008/4

N2 - Manganese 5,10,15,20-tetrakis(N-methyl-2-yl) porphyrin (MnT2MePyP) was introduced to hemoglobin to use it as a drug carrier. Reconstituted hemoglobin was reacted with pyridoxal-5-phosphate and borohydride to yield pyridoxalated reconstituted hemoglobin (PLPrHb). The reaction of PLPrHb with activated polyethyleneglycol gave pegylated reconstituted hemoglobin (PEGrHb). PEGrHb was polymerized using glutaraldehyde to yield cross-linked pegylated reconstituted hemoglobin (Cross-link PEGrHb). The number average moleculer weight of Cross-link PEGrHb was estimated to be 1.0 _Xt 105 by GPC. The modification of hemoglobin was checked by using SDS-PAGE. Stopped flow analysis showed a high SOD activity of Cross-link PEGrHb. A pharmacokinetic study of 125I-labelled Cross-link PEGrHb that was infused into mice revealed a long-term blood circulation. The novel Manganese porphyrin modified hemoglobin complex was found to remain long-term in the blood circulation without being removed by excretion. These results showed that this complex can be used as a high performance antioxidant.

AB - Manganese 5,10,15,20-tetrakis(N-methyl-2-yl) porphyrin (MnT2MePyP) was introduced to hemoglobin to use it as a drug carrier. Reconstituted hemoglobin was reacted with pyridoxal-5-phosphate and borohydride to yield pyridoxalated reconstituted hemoglobin (PLPrHb). The reaction of PLPrHb with activated polyethyleneglycol gave pegylated reconstituted hemoglobin (PEGrHb). PEGrHb was polymerized using glutaraldehyde to yield cross-linked pegylated reconstituted hemoglobin (Cross-link PEGrHb). The number average moleculer weight of Cross-link PEGrHb was estimated to be 1.0 _Xt 105 by GPC. The modification of hemoglobin was checked by using SDS-PAGE. Stopped flow analysis showed a high SOD activity of Cross-link PEGrHb. A pharmacokinetic study of 125I-labelled Cross-link PEGrHb that was infused into mice revealed a long-term blood circulation. The novel Manganese porphyrin modified hemoglobin complex was found to remain long-term in the blood circulation without being removed by excretion. These results showed that this complex can be used as a high performance antioxidant.

KW - Antioxidant

KW - Cross-link

KW - Hemoglobin

KW - Manganese porphyrin

UR - http://www.scopus.com/inward/record.url?scp=44649138063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649138063&partnerID=8YFLogxK

U2 - 10.1295/koron.65.277

DO - 10.1295/koron.65.277

M3 - Article

VL - 65

SP - 277

EP - 282

JO - Kobunshi Ronbunshu

JF - Kobunshi Ronbunshu

SN - 0386-2186

IS - 4

ER -